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Abstract  
AIM: We aimed to investigate the sensitivity, reproducibility and validity of the commercial ELISA kits for 
quantitative detection of TNF-α and their potential application for screening purposes in patients with ICH.  
METHODS: Analysis of six independent standard series, evaluation of the deviation of the TNF-α concentration in 
patients with ICH, standard addition and visual analysis of whole UV-Vis spectra were carefully performed.  
RESULTS: Low standard deviations of the absorbance were detected for every standard, as well as in the 
samples of healthy controls and patients with ICH. The standard addition series have also confirmed high 
sensitivity and reproducibility of the assay, with a congruent shift of the standard curves with the concentration of 
TNF-α for the added plasma. The visual analyses of the gained spectra have revealed the absence of any matrix 
effects from the addition of the human plasma in the reconstituted standards.  
CONCLUSION: The commercial ELISA kits can be used in the clinical practice for screening purposes of the 
plasma TNF-α levels in patients with ICH. 
 
 
 
 
 
 
 
Introduction 
 
Tumor necrosis factor-α (TNF-α) is an 
important pro-inflammatory mediator in both 
physiological and pathological states, often 
considered as a central regulator of the inflammatory 
processes [1]. A vast number of studies have revealed 
the crucial role of TNF-α in the pathogenesis of 
inflammation and rheumatic arthritis [2], in the 
pathogenesis of type-2 diabetes mellitus [3], 
atherosclerosis, myocardial ischemia and heart failure 
[4], in the treatment of cancer [5], in 
neuroinflammation and neurodegeneration [6], as well 
as in the physiology of ageing [7]. These findings were 
repeatedly confirmed and commonly cited over the 
years, and therefore, the necessity for fast and 
reproducible tests for its detection is important, both 
from the basic fundamental scientific approach and 
also from the applicative approach for its future 
implementation as a potential biomarker. 
In the past several years, several studies 
have shown that TNF-α is one of the key constituents 
of the inflammatory cascade that follows intracerebral 
haemorrhage (ICH), immediately after the bleeding 
[8]. The huge importance of the TNF-α levels in the 
clinical practice are mainly connected with the 
contribution of its up-regulation to the increase of the 
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blood-brain barrier permeability [9] and the formation 
of the peri-hematomal edema [10], [11], a significant 
predictor of bad neurological outcome in patients with 
ICH [12]. TNF-α was also reported as a link between 
neuroinflammation and excitotoxicity [13], and his role 
as a predictor of bad neurological outcome in patients 
was proven in some studies [14].  
Bearing in mind the potential role of TNF-α as 
a predictor for edema formation and bad neurological 
outcome in patients with ICH, in this study we aimed 
to investigate the sensitivity, reproducibility and 
validity of the commercial ELISA kits for quantitative 
detection of TNF-α and their potential application in 
screening of the TNF-α levels in patients with ICH. 
 
 
Methods 
 
All measurements were performed using the 
Human TNF-alpha Quantikine ELISA Kit, from 
Quantikine (cat. Number: DTA00C), according to the 
manufacturer’s instructions. To minimize any errors 
that can arise from using different buffers and 
incubation times. All measurements were performed 
on the same microtiter plate, using the same solutions 
and under careful control of the environmental 
conditions (especially temperature) by the same 
person. We have implemented several approaches: 
analysis of the standard series, evaluation of the 
deviation of the TNF-α concentration in patients with 
ICH, standard addition and analysis of whole UV-Vis 
spectra. 
The standard series were made according to 
the manufacturer’s instructions; briefly, the lyophilized 
TNF-α was reconstructed with ddH2O to a stock 
solution of 10,000 pg/mL, and the Calibrator Diluent 
RD6-35 was used to produce a dilution series with the 
following concentrations: 500, 250, 125, 61.5, 31.2 
and 15.6 pg/mL TNF-α. Six dilution series were 
prepared to compare the differences in the gained 
absorbance. Blood plasma TNF-α levels at admission 
were evaluated in two men patients with ICH (CSS 
score 3.0 with initial ICH volume of 63 cm
3,
 and CSS 
score 7.5 with an initial volume of ICH 70 cm
3
, 
respectively) and two age-matched healthy controls. 
All participants have given informed consent. For the 
preparation of the standard addition series, we have 
diluted the 500 pg/mL standard 1:1 with blood plasma 
form patients or healthy controls (instead of using the 
Calibrator Diluent RD6-35), in this way resulting in 250 
pg/mL recombinant human TNF-α standard that 
additionally contains extra TNF-α from the blood 
plasma. A dilution series was then prepared, resulting 
in the following concentrations: 250, 125, 61.5, 31.2 
and 15.6 pg/mL TNF-α. 
The absorbance at 450 nm was recorded 
using the ELISA microplate reader Spectra Max 190, 
Molecular Devices. Additionally, in some cases, we 
have recorded the whole spectra and visualised them 
with the SoftMax Pro 7 software. All results were 
statistically analyzed in Microsoft Excel 2016.  
 
 
Results  
 
Standard series  
In this study, we have analysed the 
absorbance of six standard series. The results 
concerning the average absorbance values of each 
standard and their standard deviation are summarized 
in the next table (Table 1).  
Table 1: Average absorbance and standard deviation of the 
absorbance for each standard in six dilution series 
Standards Concentration 
(pg/mL) 
Number of 
independent 
measurements 
A450 ± SD Min value of 
A450 
Max value of 
A450 
1 500.0 6 1.1704 ± 0.04 1.1026 1.1878 
2 250.0 6 0.7454 ± 0.02 0.7136 0.7699 
3 125.0 6 0.4815 ± 0.01 0.4678 0.4906 
4 61.5 6 0.3219 ± 0.01 0.3066 0.3451 
5 31.2 6 0.1683 ± 0.01 0.1405 0.1904 
6 15.6 6 0.0880 ± 0.01 0.0821 0.0983 
 
 
The curve fit of each of these standard series 
is represented in Figure 1. As it can be seen, the 
dependence of the signal on the concentration of 
TNF-α is not linear, and a trend towards forming a 
mild plateau can be noticed for the values of TNF-α 
higher than 300 pg/mL. This trend was detected in 
each of the standard series. And after our statistical 
analyses, we have detected that the polynomial 
regression of second order gives the best curve fit for 
the dependence between the absorbance and TNF-α 
concentration. The R
2
 values of the polynomial 
regression model ranged from 0.9921 till 0.9958. 
Moreover, except the obvious trend for a mild plateau, 
the increase in the values of the standard deviance 
can be detected for the higher concentrations of TNF-
α. Namely, the range of the absorbance for the 
standards with low TNF-α concentration was also low 
(for instance 0.0162 for the standard with a 
concentration of 15.6 pg/mL) versus the range for the 
absorbance of the standard with the highest 
concentration of 500 pg/mL which had eight times 
bigger range (0.0852). It seems that the sensitivity of 
the instrumental method is dependent on the 
concentration of TNF-α. However, it should be noted 
that except for the standard with 500 pg/mL TNF-α. 
We have detected a very good congruence of the 
values of the absorbance for the standards in each of 
the six independent series, which suggests high 
reproducibility of the method.  
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Figure 1: Standard series and series of standard additions using 
blood plasma of healthy controls and patients with ICH 
 
 
Deviation of the detected TNF-α 
concentration in patients and healthy 
controls 
The concentration of TNF-α in patients and 
healthy controls was estimated in eight independent 
measurements. The average concentration of TNF-α 
and the standard deviation of the values for these 
measurements are presented in Table 2. 
Table 2: Deviation of the TNF-α concentration in patients and 
healthy controls 
Subjects Number 
of 
measure-
ments 
c ± SD Min value of the 
concentration 
Max value of the 
concentration 
Healthy control 1 8 22.99 ± 0.43 pg/mL 22.36 pg/mL 23.84 pg/mL 
Healthy control 2 8 17.41 ± 0.49 pg/mL 16.67 pg/mL 17.87 pg/mL 
Patient with ICH 1 8 126.92 ± 0.88 pg/mL 125.82 pg/mL 128.44 pg/mL 
Patient with ICH 2 8 158.67 ± 0.68 pg/mL 157.98 pg/mL 159.53 pg/mL 
 
As it can be seen, there is very small 
deviation of the estimated concentrations of TNF-α 
both in healthy controls and in patients with ICH. 
These results indicate high reproducibility of the 
method.  
 
Standard additions 
The series of standard additions using both 
blood plasma of the healthy controls and patients with 
ICH have shown a good curve fit (R
2
 values of 0.9994 
and 0.9995 for the healthy controls; 0.9993 and 
0.9963 for the patients with ICH. respectively). The 
curves possessed the same characteristics as the 
curves from the standard series: namely, again the 
polynomial regression of second order was estimated 
as the best fit for the dependence between the 
measured signal and the concentration, with the same 
mild trend for plateau towards the highest TNF-α 
value. The series with standard addition using plasma 
from healthy controls have shown a trend for slightly 
higher values of the absorbance, especially evident 
for the low standards with 15.6 and 31.2 pg/mL TNF-
α, whereas the absorbance of the standard with a high 
concentration of TNF-α (250 pg/mL) did not show 
evident differences with the absorbance of the six 
standard series. In contrast, the series of standard 
addition using plasma from ICH patients have shown 
a drastic shift of the curve towards highest values of 
the absorbance. Having in mind that we have 
detected quite higher TNF-α level in the blood plasma 
of the patients, this result only stresses the high 
sensitivity and reproducibility of the method. 
To detect potential matric effects of the added 
blood plasma to the reconstituted TNF-α standard. we 
have also recorded and analyzed the whole UV-Vis 
spectra. Neither of the examined spectra showed any 
shift of the baseline. All of the spectra were 
characterized by one sharp peak of the absorbance 
with λmax of 450 nm. Excluding any matrix effects 
and proving high sensitivity (Figure 2). 
 
Figure 2: UV-Vis spectra of the standard additions using blood 
plasma from healthy controls. а) Standard of 15.6 pg/mL (λmax = 
0.1787). б) Standard of 31.2 pg/mL (λmax = 0.2205) 
 
 
Discussion 
 
The detrimental effects of TNF-α towards the 
secondary brain injury after ICH were well 
documented in the past years using animal models for 
ICH [15]. [16]. Recently, Behrouz (2016) [8] have 
proposed a model explaining that the produced 
thrombin levels after ICH trigger up-regulation and 
release of TNF-α in the brain tissue and thus. 
contribute to the secondary brain injury.  
Several studies have also evaluated the 
peripheral TNF-α level in patients with ICH. For 
instance, increased peripheral levels of TNF-α were 
detected in patients with bad neurological outcome. 
when compared with the patients with a good 
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outcome [17]. Yang and Shao (2016) [18] have 
detected higher TNF-α levels in patients with ICH 
when compared to healthy controls with a peak in the 
concentration three days after ICH. In both of these 
studies, commercial ELISA kits were used for the 
quantitative detection of TNF-α. 
In the present study, we have applied several 
methods to examine the specificity and the 
reproducibility of the ELISA method for quantitative 
detection of TNF-α. The literature data for the studies 
of this type are rare, and especially in the case of 
patients with ICH or ischemic stroke. For instance, 
hitherto low-cost sandwich ELISA procedures were 
validated for the measurement of TNF-α in bovine 
plasma [19] and the early stages of heart failure [20]. 
However, the analyses of the whole spectra and 
evaluation of the matrix effects have not been 
performed in any of these studies. 
In this study, we have shown high 
reproducibility of the ELISA method for detection of 
TNF-α. Low standard deviations of the absorbance 
were detected for every standard in the series, as well 
as in the samples of healthy controls and patients with 
ICH. The standard addition series have also 
confirmed high sensitivity and reproducibility, with a 
reasonable shift of the standard curves according to 
the concentration of TNF-α for the added plasma.  
The visual analyses of the gained spectra 
have revealed the absence of any matrix effects from 
the addition of the human plasma in the reconstituted 
standards. All of these results suggest that the 
commercial ELISA kits can be used in the clinical 
practice for the screening of the TNF-α level in 
patients with ICH.  
We believe that the implementation of this 
assay could be beneficial for the prediction of the 
volume of the oedema and the neurological outcome 
of the ICH patients, which will we in the focus of our 
next studies?  
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